Panniculitis in Dermatomyositis
Eligible age
1+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Adipose tissue involvement is rare in dermatomyositis. The occurrence of partial or diffuse lipodystrophy is a rare but well-characterized manifestation, particularly in juvenile forms of dermatomyositis. Panniculitis, on the other hand, is exceptional and rarely described in the literature, mostly in the form of clinical cases. Panniculitis in dermatomyositis is exceptional. There are no validated diagnostic criteria or treatment recommendations. Treatment is based, by analogy, on the therapeutic strategy for lupus panniculitis and involves synthetic antimalarials combined with steroids and/or immunosuppressants. The aim of this study is to describe panniculitis in dermatomyositis in order to determine whether there are clinical or histological characteristics that distinguish it from other causes of panniculitis, particularly panniculitis associated with lupus erythematosus.
Sponsor: University Hospital, Strasbourg, France
You may qualify if…
- ✓ Subject aged 1 year and older
- ✓ With a confirmed diagnosis of dermatomyositis
- ✓ With a confirmed diagnosis of panniculitis
You may not qualify if…
- ✕ Panniculitis for which another cause has been established, particularly infectious and metabolic panniculitis
Source: ClinicalTrials.gov · NCT07345949 · last updated 2026-01-16